SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044736
Filing Date
2024-11-12
Accepted
2024-11-12 16:01:46
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1253711
2 ex31-1.htm EX-31.1 17897
3 ex31-2.htm EX-31.2 17856
4 ex32-1.htm EX-32.1 7772
  Complete submission text file 0001493152-24-044736.txt   5686087

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE fblg-20240930.xsd EX-101.SCH 37667
6 XBRL CALCULATION FILE fblg-20240930_cal.xml EX-101.CAL 50590
7 XBRL DEFINITION FILE fblg-20240930_def.xml EX-101.DEF 204285
8 XBRL LABEL FILE fblg-20240930_lab.xml EX-101.LAB 333037
9 XBRL PRESENTATION FILE fblg-20240930_pre.xml EX-101.PRE 286884
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 797352
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 241447778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)